702 filings
Page 8 of 36
424B3
0o8yoh 8ddiqkwjavrd9
2 Apr 18
Prospectus supplement
12:00am
EFFECT
3bw kstbs
2 Apr 18
Notice of effectiveness
12:00am
CORRESP
pjyk2eahgo6z15ewxi
27 Mar 18
Correspondence with SEC
12:00am
UPLOAD
snyy8ijf kf9i
27 Mar 18
Letter from SEC
12:00am
8-K
w6mez
22 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
ok26lcs11 u2iy
19 Mar 18
CytRx Reports 2017 Financial Results
12:00am
8-K
sle zo3lwdlw13
1 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
3vpw warp1
9 Nov 17
CytRx Reports Third Quarter 2017 Financial Results
12:00am
8-K
q30u6v6i3r9 nxf
8 Nov 17
CytRx Announces Strategic Realignment of Clinical Development Team
12:00am
8-K
gjym 4skdz6b6fs
1 Nov 17
CytRx Corporation Announces Results from Special Meeting of Stockholders
12:00am
8-K
kooq w9gsfl87dv21cu9
19 Oct 17
CytRx Corporation Announces Outcome of Nasdaq Hearing
12:00am
8-K
aei6qk9q7omcggsvcwot
5 Oct 17
Other Events
12:00am
8-K
4ytq nxfym8oy0c
21 Sep 17
Other Events
12:00am
CT ORDER
6la0muoprt 1bdohu
15 Sep 17
Confidential treatment order
12:00am
8-K
uawyaif5ji2khos6xtu8
13 Sep 17
CytRx Corporation Announces Amendment to Definitive Proxy Statement for Upcoming Special Meeting
12:00am
DEFA14A
scu1h
13 Sep 17
Additional proxy soliciting materials
12:00am
8-K
t574tbm0 4yuav3qhz8
30 Aug 17
CytRx Corporation Files Definitive Proxy Statement for Upcoming Special Meeting
12:00am